Key Takeaways
- A DSO acquisition usually follows five stages: sourcing, financial evaluation, letter of intent, diligence with quality-of-earnings review, and post-sale transition under three contracts.
- Normalized EBITDA can be the core valuation metric, and documented add-backs help protect the final purchase price.
- Headline price is not net proceeds, because deal structure splits value across cash, rollover equity, and earnout, each with different risk.
- Competitive tension from multiple vetted buyers can help protect value through diligence and support better post-sale contract terms.
- McLerran & Associates provides CPA-led valuation, buyer competition, and contract negotiation to help Cleveland sellers improve outcomes.
Discuss Your Cleveland Practice In A Confidential Call With McLerran & Associates.
Who This Guide Is For And Key Terms To Know
This guide is written for Cleveland-area owners of premier dental practices, generally those generating $1.5 million or more in annual collections, who are weighing a DSO affiliation after receiving outreach from a buyer.
Before walking through the stages, review a few foundational terms:
- EBITDA: Earnings before interest, taxes, depreciation, and amortization. DSOs use this profit figure to value a practice.
- Add-backs: Expenses that are personal, discretionary, or non-recurring and are added back to reported profit to show true operating earnings.
- Normalized EBITDA: Reported EBITDA adjusted with add-backs to reflect what the practice would earn under a new owner.
- Valuation: The estimated dollar value of the practice, typically expressed as a multiple of normalized EBITDA.
- Letter of intent (LOI): A non-binding document that sets the headline price and principal deal terms before diligence begins.
- Diligence: The buyer’s detailed review of financials, operations, and legal documents to verify what was represented.
- Quality of earnings (QoE): A formal financial analysis, usually performed by the buyer’s accountants, that tests whether the seller’s EBITDA and add-backs are supportable.
- DSO (Dental Service Organization): A company that acquires the non-clinical, business side of a dental practice and provides management services under contract.
- Rollover equity: A portion of the sale proceeds reinvested as ownership in the DSO platform rather than taken as cash.
- JV-level equity: Rollover held at the individual practice (joint-venture) level, typically with distributions and a higher floor but lower ceiling.
- Holding-company-level equity: Rollover held in the DSO’s parent company, usually with no distributions but a higher ceiling at the platform’s next sale.
- Earnout: Additional consideration paid after closing, contingent on hitting agreed performance targets.
- Management services agreement (MSA): The long-term contract under which the DSO provides non-clinical services in exchange for a management fee.
- Employment agreement: The contract governing the selling dentist’s post-sale clinical role, compensation, and schedule.
In 2026, DSO and private-equity consolidation continues across Ohio. Demand remains strong for premier, Class A practices, and valuations sit near historic highs. Outcomes can vary by practice size, specialty, profitability, and owner goals. This guide is educational, not regulated investment or tax advice, and owners should consult their own advisors before making any transaction decision.
Talk With A McLerran Advisor About Your Practice’s Value.
Stage 1: Sourcing And First Contact
A DSO identifies a Cleveland practice through several channels, including unsolicited letters or calls, outbound outreach from acquisition teams, broker networks, study clubs, and referrals from other affiliated dentists. The first conversation is typically framed as exploratory, a chance to discuss the practice’s profile and the DSO’s interest.
The DSO’s acquisition team runs this process every week. They know what questions to ask, how to anchor a valuation early, and how to create urgency. An unsolicited offer reflects the buyer’s underwriting model and its return requirements, not an independent assessment of your practice’s value.
Seller leverage point: The owner controls whether and when the process starts. An unsolicited offer is only a starting point. Engaging a sell-side advisor before responding to any buyer helps preserve that control.
Stage 2: Financial Evaluation And Valuation
Once a DSO expresses serious interest, it requests financial information to build its own valuation. The methodology centers on normalized EBITDA. The buyer starts with reported operating profit, adds back owner-specific and non-recurring expenses, then replaces the owner-dentist’s compensation with the market cost of a replacement associate. The result is a transferable earnings figure the buyer multiplies to arrive at an indicative enterprise value.
Indicative EBITDA multiples in dental M&A can range broadly depending on practice size, specialty, provider depth, revenue durability, growth trajectory, and payer mix. Specialty practices can command premiums above general dentistry, and platform-tier groups above $10 million in adjusted EBITDA can reach higher still. These are indicative ranges, and each practice’s multiple depends on its own numbers and market.
Several factors can move a multiple higher, including strong hygiene economics, associate-led production, fee-for-service payer mix, consistent new-patient flow, and multi-location scale. Factors that can compress it include heavy owner dependence, Medicaid concentration, deferred technology investment, and short lease terms.
Seller leverage point: A CPA-led, diligence-grade valuation done before going to market helps control the narrative around EBITDA and keeps the buyer from setting the anchor. McLerran & Associates builds this analysis up front, unpacking every add-back, replacing owner compensation at market rate, and arriving at a defensible number that can hold under buyer scrutiny.
Stage 3: Letter Of Intent And Deal Structure
When a buyer is ready to move forward, it issues a letter of intent. The LOI sets the headline enterprise value and the deal structure, which divides the purchase price among cash at close, rollover equity, and earnout. Each component affects risk and timing, so headline price rarely matches net proceeds.
Based on general dental-consolidation reporting, a typical DSO deal structure can include:
- Cash at close: Often 60–80% of headline enterprise value.
- Rollover equity: Often 15–30% of consideration, held at either the JV (practice) level or the holding-company (DSO parent) level. As much as 40% of a DSO deal can be paid in equity rather than cash, meaning the owner is effectively underwriting the DSO as an investment.
- Earnout: Often 5–15% of consideration, tied to post-close production or EBITDA targets over 1–3 years.
The LOI also typically includes an exclusivity period, a window during which the seller agrees not to speak with other buyers. Granting exclusivity before structure is fully defined gives the buyer significant leverage.
Seller leverage point: Competitive tension among multiple vetted buyers is what moves cash at close and earnout terms. A seller who enters exclusivity with only one offer has already surrendered the most powerful negotiating tool available.
See How Your Potential Deal Structure Compares In A Confidential Review.
Stage 4: Diligence, Quality Of Earnings, And Closing
After the LOI is signed, the buyer’s team conducts formal diligence. This typically spans 45 to 75 days. The buyer reviews financials and tax returns, production by provider, hygiene reports, and accounts receivable aging. It also examines payer mix, employment agreements, lease documents, equipment schedules, and compliance records.
The centerpiece of DSO diligence is the quality-of-earnings review. The buyer’s accountants test every add-back the seller claimed. Any add-back that cannot be documented with invoices, payroll records, or a reconciliation schedule is at risk of being struck. Because the purchase price is a multiple of EBITDA, every dollar struck is multiplied away. A $50,000 unsupported add-back at a 7x multiple removes $350,000 from the closing check.
This stage is also where deals can be re-traded. If the buyer’s QoE lands materially below the seller’s reported EBITDA, a purchase price reduction often follows. Roughly 15–20% of practices that sign LOIs never close, and unprepared sellers can close significantly below the LOI multiple.
Seller leverage point: A defensible valuation built before going to market, along with other vetted bidders waiting in the wings, can help hold the agreed value through diligence. McLerran & Associates provides quality-of-earnings defense through this stage and reminds buyers that other qualified offers exist if they attempt to retrade.
Stage 5: Post-Sale Transition And The Three Contracts
Closing begins a new operating relationship governed by three contracts that independently affect take-home pay and clinical autonomy.
- Purchase agreement: The binding contract that replaces the LOI, detailing representations, remedies, purchase-price allocation, and closing mechanics.
- Employment agreement: Governs the selling dentist’s post-sale clinical role, compensation, schedule, non-compete, and clawback provisions. Indicative dentist compensation in DSO structures is often in the range of 28–32% of collections, though terms vary by deal and market.
- Management services agreement (MSA): The long-term operational contract under which the DSO provides non-clinical services, such as billing, HR, marketing, procurement, IT, and compliance, in exchange for a management fee, often 15–30% of collections.
A minimum 5-year working agreement is typical on a DSO deal, though a shorter work-back may be possible depending on the practice’s associate depth and the buyer’s requirements. These terms are negotiable before signing, and they become difficult to change afterward.
Seller leverage point: An experienced advisor negotiates all three contracts on the owner’s behalf before exclusivity is granted and before the buyer controls the process.
Have Your Post-Sale Contracts Reviewed Before You Sign.
How DSOs Value A Cleveland Practice: Add-Back Decisions In Practice
Normalized EBITDA forms the foundation of most DSO valuations, and the add-back list can change that number meaningfully. Common add-backs in dental practice QoE analysis include owner-doctor compensation above the market rate for a replacement associate, related-party rent adjusted to market, personal-use expenses run through the practice, one-time or non-recurring costs, and above-market family-member payroll.
The same practice can be valued very differently depending on who performs the analysis and how aggressively add-backs are claimed and documented. A buyer’s QoE will strike any add-back that lacks a clear paper trail. The number set before going to market becomes the anchor for everything that follows, so an unsupported valuation can be vulnerable in diligence.
McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis before any practice goes to market, unpacking every add-back, documenting each adjustment, and arriving at a number that any accountant would recognize as best-in-class. For more on how valuation works in the Cleveland context, see DSO Affiliation Options In Cleveland For $1.5M+ Practices.
Deal Structure Details: Cash, Rollover Equity, And Earnouts
A DSO offer is a package of components, and each one can look very different once analyzed on its own terms.
Cash at close is the most certain component. As noted in Stage 3, cash at close typically covers a majority of headline enterprise value, and the exact percentage depends on practice profile and buyer strategy.
Rollover equity is reinvested ownership in the DSO platform. It can be held at the JV level, where distributions are common and the floor is higher but the ceiling is lower. It can also be held at the holding-company level, where there are no distributions but the ceiling can multiply several times over at the platform’s next sale. Rollover value depends on the DSO’s future performance, governance, leverage, and exit timing. That means sellers should underwrite the DSO like an investment, asking whether the platform is profitable, whether revenue is growing at existing offices, whether the management team is experienced, and whether the private equity backing is sound.
Earnouts are contingent payments tied to post-close performance targets, typically EBITDA or production over 1–3 years. A non-punitive earnout can include provisions like pro-rata payouts for near-misses and a later start date to account for integration disruption. When the DSO controls expenses, headcount, and pricing post-close, the buyer effectively controls whether the seller’s earnout is achievable.
Two offers with the same headline multiple can produce very different results once rollover value, earnout risk, and post-close compensation are counted. McLerran & Associates produces multi-year, multi-structure financial forecasting so owners can compare real after-tax cash across deal structures, not just headline numbers. See also Selling Your Cleveland Dental Practice To A DSO for additional context on deal structure mechanics.
The Three Post-Sale Contracts And Daily Life After Closing
Post-sale contracts shape both income and autonomy for years, so a closer look can help owners prepare. Most competitor content mentions these agreements briefly, but the details often drive how the affiliation feels day to day.
The purchase agreement is the binding legal contract that replaces the LOI at closing. It details the seller’s representations about the practice and the remedies if one proves incorrect. It also sets the final non-compete terms and how the purchase price is allocated among asset classes. Most dental practice sales are structured as asset sales, meaning the buyer purchases equipment, records, and goodwill rather than the seller’s corporate entity. Purchase-price allocation matters for taxes, because goodwill is generally taxed at capital-gains rates, while equipment depreciation recapture and non-compete payments are taxed as ordinary income. Sellers can benefit from working with a CPA experienced in dental transactions before agreeing to any allocation.
The employment agreement governs the selling dentist’s post-sale clinical life. It sets compensation, often around 28–32% of collections for a general practitioner, along with minimum production expectations, clawback thresholds, vacation and CE days, and the non-compete radius and duration. Non-compete terms in DSO deals commonly run several years and cover a meaningful geographic radius, which in a dense metro area like Cleveland can significantly limit future options. These terms remain negotiable before signing.
The management services agreement (MSA) is the operational contract that governs the practice for the duration of the seller’s affiliation, often 10 to 15 years or more. It defines the management fee, often 15–30% of collections, and the services the DSO provides. It also outlines what the DSO controls, from hiring to scheduling software, supply contracts, and marketing. The MSA sets exit terms as well. Three MSA clauses can be particularly consequential: the fee escalator, the change-of-control clause, and the term and termination provisions.
The MSA fee and employment compensation affect take-home income independently and at the same time. A seller who negotiates a strong headline price but accepts an above-market MSA fee and below-market employment compensation can end up earning less post-sale than expected. An experienced advisor negotiates all three contracts together and models the total economic package, not just the closing check.
For a deeper look at how these contracts interact with clinical autonomy, see Cleveland DSO Affiliation: How To Protect Practice Value.
What Sellers Get Wrong
The “DSOs scam us” sentiment that appears in online forums is real, and it usually reflects process problems rather than an inherent DSO issue. Several recurring seller mistakes appear in Cleveland transactions.
- Accepting the first unsolicited offer. An unsolicited offer is a buyer’s opening bid, anchored to the buyer’s return requirements. Sellers who accept it without running a competitive process often leave significant value on the table.
- Letting the buyer set the valuation. A “free” valuation from a DSO or a generalist broker often functions as a lead magnet. As noted earlier, an unsupported valuation can be challenged in diligence, and the deal can be repriced after the seller has already stopped talking to other buyers.
- Talking to only one DSO. This removes the competitive tension that could otherwise push cash at close higher and clean up earnout terms. A seller negotiating with one buyer faces a counterparty that runs this playbook every week.
- Agreeing to punitive earnouts. When the buyer controls the inputs, an earnout becomes a contingent payment the buyer can effectively prevent.
- Signing post-sale contracts without negotiating. The MSA and employment agreement are often presented as standard. Every material term is negotiable before signing and largely fixed afterward.
Each of these reflects a process gap. Sell-side representation, a real valuation done up front, and a structured competitive process that creates genuine tension among vetted buyers can address many of these issues. For more on common pitfalls, see How To Sell Your Dental Practice to a DSO in Cleveland.
Cleveland Market Reality In 2026
Those process problems matter more in a market this active. DSO and private-equity consolidation continues across Ohio and the broader Midwest, and Cleveland is identified as one of the state’s three principal dental-market hubs. National DSO platforms with Ohio presence include several of the largest consolidators in the country, and some of the most active buyers in Ohio are out-of-state platforms treating the region as expansion territory.
Nationally, nearly 200 dental practice transactions occurred in the first half of 2026 alone, and 69% of DSOs surveyed expected to increase acquisition activity through the remainder of the year. Demand remains strong for premier, Class A practices, and valuations sit near all-time highs, though multiples may compress over the next few years as market conditions evolve. A candid advisor can explain how your specific practice is positioned in this environment. For current Cleveland and Northeast Ohio market context, see 2026 Cleveland DSO Market Trends & Buyer Activity Explained.
Why Running A Competitive Process Changes The Outcome
McLerran & Associates is a dental-only, sell-side advisor and does not represent buyers. In the Midwest, the Cleveland office is led by Justin Klingshim, with recent closings in Ohio. The firm works both the private-buyer and DSO paths in roughly equal measure, giving owners a genuine side-by-side comparison that single-lane brokers cannot provide.
The firm’s approach includes several elements:
- A CPA-led, diligence-grade EBITDA valuation done before going to market, which helps control the narrative around profitability and keeps the buyer from setting the anchor.
- A vetted national buyer pool, with poorly run DSOs removed, so owners see the real market and avoid weak buyers at the table.
- A structured, auction-like bid process typically running 45–60 days and generating around 10 offers, creating the competitive tension described in Stage 3.
- Multi-year, multi-structure financial forecasting so owners can compare real after-tax cash across deal structures and time horizons.
- Quality-of-earnings defense through diligence so the agreed value has support.
The firm’s numbers include roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, more than 10,000 practices evaluated, a transaction rate of roughly 85–90% versus an industry norm closer to 35–40%, and an average valuation roughly 30% higher than owners achieve selling on their own.
For more on how McLerran structures the DSO sell-side process, see Selling A Dental Practice To A DSO In Cleveland: 2026 Guide and DSO Partnership Benefits For Cleveland Dental Practices.
Request A Confidential, No-Obligation Strategy Call With McLerran & Associates.
Buyer-Comparison Framework: DSO Vs. Private Buyer
Not every practice is best served by the DSO path. The table below shows where the DSO and private-buyer routes diverge most, including cash certainty, work commitment, and equity exposure, so you can see which trade-offs align with your goals. Every figure is indicative and drawn from general dental-consolidation reporting, and each outcome depends on your practice’s facts.
| Attribute | DSO Offer | Private-Buyer Offer | What To Verify |
|---|---|---|---|
| Valuation basis | Multiple of normalized EBITDA; indicative ranges vary widely by size and specialty | Percentage of collections or multiple of net cash flow; indicatively 70–90% of collections for doctor-to-doctor deals | Which earnings basis applies to your practice size; confirm with a CPA-led analysis |
| Cash at close | Indicatively 60–80% of headline value | Typically 100% cash at closing for individual-dentist buyers | Confirm financing is pre-approved; verify no seller note is required |
| Post-sale work requirement | Typically 3–5 years minimum employment; 5-year terms common | Typically 4–8 weeks work-back on a walk-away sale | Review employment agreement term, clawback provisions, and non-compete radius |
| Equity component | Rollover equity indicatively 15–30%; can be up to 40% of total consideration | Rarely includes rollover equity; individual buyers typically pay all cash at close | Assess DSO platform quality, PE backing, and hold-period timeline before accepting rollover |
Consider a hypothetical illustration. A Cleveland general practice generating $1.5 million in collections receives an unsolicited DSO offer. Without a sell-side advisor, the owner has no independent EBITDA analysis, no competing offers, and no leverage on the MSA or employment terms. With McLerran & Associates, the same practice goes through a CPA-led valuation, a 45–60-day competitive bid process generating multiple offers, and negotiated post-sale contracts, with the owner comparing real after-tax proceeds across structures before choosing a path. The process, rather than the first offer, often determines the outcome.
